Ashwagandha for Perimenopause: Hormones, Sleep & HRT

Your body runs two hormonal control centres that share a single fuse box. One manages stress. The other manages reproduction. When stress blows the fuse — and for many women, it does — both systems go dark at once.

This is The Hormonal Seesaw — the mechanism that makes ashwagandha uniquely relevant to women's health. Not because it adds hormones, but because it removes the interference that tips them out of balance.

Three randomised controlled trials now test ashwagandha specifically in women: one for perimenopause symptoms (PMID: 34553463, n=100), one for menopausal symptoms (PMID: 41561822, n=60), and one for sexual function (PMID: 26504795, n=50). Four meta-analyses supply the mechanistic foundation. Here is what the evidence actually says — and where it runs out.

The Hormonal Seesaw: Why Stress Disrupts Women's Hormonal Balance Differently

Chronic stress does not affect hormonal balance equally across sexes. In women, the HPA axis — the cortisol-producing stress response system — interacts directly with the hypothalamic-pituitary-gonadal (HPG) axis that governs oestrogen and progesterone production. When one axis is dysregulated, the other follows.

The mechanism is specific. Cortisol and progesterone share a precursor hormone: pregnenolone. Under sustained stress, the body diverts pregnenolone toward cortisol production at the expense of progesterone synthesis — a phenomenon sometimes called "pregnenolone steal." The downstream effects cascade: lengthened or shortened menstrual cycles, delayed or suppressed ovulation, and amplified hormonal fluctuations during perimenopause.

A 2025 meta-analysis of 12 RCTs (PMID: 40746175, total n=488) confirmed that ashwagandha produces significant cortisol reduction compared to placebo. A separate 2024 meta-analysis (PMID: 39348746, total n=558) found consistent benefits for stress and anxiety measures across trials that included significant proportions of female participants.

However, here is the critical caveat: the 2025 cortisol meta-analysis (PMID: 40746175) found no significant effect on perceived stress despite reducing serum cortisol. Biological marker improvement did not translate to subjective stress improvement in pooled analysis. This matters — it means cortisol reduction alone may not resolve how stressed you feel.

What Three Women-Specific Trials Show

Perimenopause (PMID: 34553463, n=100)

This 2021 double-blind RCT remains the strongest women-specific trial. One hundred perimenopausal women received either 300 mg ashwagandha root extract twice daily or placebo for 8 weeks. The ashwagandha group showed statistically significant reductions in total Menopause Rating Scale scores (p < 0.0001), spanning psychological symptoms (p = 0.0003), somato-vegetative symptoms (p = 0.0152), and urogenital symptoms (p < 0.0001).

Critically, this trial also measured hormones: the ashwagandha group showed a significant increase in serum oestradiol (p < 0.0001) and reductions in FSH (p < 0.0001) and LH (p < 0.05) compared to placebo. This is the only RCT demonstrating measurable hormonal changes in women taking ashwagandha.

Menopause (PMID: 41561822, n=60)

Published in January 2026, this newer RCT tested ashwagandha root extract in 60 menopausal women aged 45–55 for 56 days. Results replicated the earlier perimenopause findings: significant reductions in MRS scores across psychological (p < 0.0001), somatic (p < 0.0001), and urogenital (p < 0.0001) domains. Hormonal improvements were again observed — increased oestradiol (p < 0.001) and progesterone (p < 0.001), reduced FSH (p < 0.001) and LH (p < 0.001). Hot flash frequency also decreased significantly (p < 0.001).

Sexual Function (PMID: 26504795, n=50)

A pilot study of 50 healthy women receiving 300 mg ashwagandha root extract twice daily for 8 weeks found significant improvements in Female Sexual Function Index scores for arousal (p < 0.001), lubrication (p < 0.001), orgasm (p = 0.004), and satisfaction (p < 0.001), along with reduced sexual distress (p < 0.001) and increased successful sexual encounters (p < 0.001).

This is a pilot study — smaller sample, no hormonal measurements — but it adds to the picture of ashwagandha addressing stress-related disruption in women's physiology.

"Ashwagandha root extract can be a safe and effective option to relieve mild to moderate climacteric symptoms during perimenopause in women." — Gopal et al. (2021), J Obstet Gynaecol Res

What the Evidence Does Not Show

Honesty about limitations is where real expertise lives. Here is what the current research does not demonstrate:

No PCOS-specific trials. The theoretical basis for ashwagandha in PCOS relates to cortisol's role in insulin resistance and androgen excess. This is biologically plausible. But no dedicated PCOS RCT has been completed. Do not take ashwagandha expecting it to resolve PCOS symptoms — the evidence simply is not there yet.

No female fertility outcomes. There is no human research suggests benefits for ashwagandha improving female fertility. The male fertility data exists (PMID: 35993457, systematic review of herbal medicines for male infertility, n=1,218), showing reduced FSH and improved semen parameters — but this does not translate to female fertility research.

No large oestrogen-level trials. While the perimenopause and menopause RCTs showed increased serum oestradiol, most studies on the mechanistic pathway were animal or in vitro models. The human evidence is limited to two trials of 100 and 60 participants respectively. Confirmation at scale is needed.

Stress vs stress perception gap. The 2025 cortisol meta-analysis (PMID: 40746175) found no significant effect on perceived stress despite reducing cortisol. This suggests ashwagandha's mechanism may work better at the biological level than the subjective experience level. A 2023 RCT (PMID: 37740662, n=60) in overweight middle-aged adults did not demonstrate significant stress reduction versus placebo on the primary Perceived Stress Scale outcome, although it did find significant fatigue reduction (p = 0.016).

Perimenopause and Menopause: Where the Evidence Is Strongest

Perimenopause is characterised by erratic oestrogen and progesterone fluctuations, rising cortisol sensitivity, sleep disruption, anxiety, and cognitive fog. This is almost precisely the symptom cluster for which ashwagandha has the strongest evidence — stress reduction, sleep improvement, anxiety reduction, and cortisol modulation.

A 2021 sleep meta-analysis (PMID: 34559859, 5 RCTs, total n=400) found ashwagandha significantly improved sleep quality, with effects more pronounced at doses used in studies of 600 mg or more and in treatment durations of 8 weeks or longer. For women navigating the sleep disruption of perimenopause, this is directly relevant.

Between the two dedicated menopause/perimenopause RCTs (PMID: 34553463 and PMID: 41561822), the evidence base for ashwagandha in menopausal symptom management is among the strongest for any non-hormonal supplement in this population. It does not replace oestrogen. It does not address vasomotor symptoms through the same mechanism as hormone therapy. But for the stress, sleep, and psychological components, the evidence is now replicated.

Thyroid: A Bidirectional Consideration

A 2023 systematic review of herbal medicines for hypothyroidism (PMID: 37013429) identified ashwagandha as one of the botanicals with preliminary evidence for thyroid support, particularly in subclinical hypothyroidism. Thyroid dysfunction disproportionately affects women — approximately 1 in 8 will develop a thyroid condition in their lifetime.

However, this cuts both ways. Women with hyperthyroidism or autoimmune thyroid conditions (Hashimoto's or Graves' disease) should exercise caution. Ashwagandha's thyroid-stimulating potential means it is not suitable for everyone, and thyroid function should be monitored. See our detailed thyroid article for the full analysis.

From Our Formulations

Teelixir's ashwagandha is sourced from Rajasthan, India — the Di Tao (original source) region where Withania somnifera has been cultivated for centuries. We use 100% root material, never leaf. This matters because the clinical trials showing benefits for women (PMID: 34553463, 41561822, 26504795) all used root extract — not leaf, not root-and-leaf blends.

Our dual-extraction process uses both hot water and ethanol to capture the full withanolide spectrum. COA-verified minimum 2.5% withanolides at every batch. 10:1 extraction ratio. ACO certified organic. Third-party tested for heavy metals and microbial contamination.

This is a meaningful differentiator. Many commercial ashwagandha products use root-and-leaf blends (cheaper to produce) or single-extraction methods that miss ethanol-soluble compounds. The leaf contains higher concentrations of withaferin A, which has cytotoxic properties that may not be desirable for daily supplementation. Root-only extraction, as used in the clinical trials and in our product, avoids this concern.

What This Means in Practice

For stress-related hormonal disruption: If your primary driver is chronic stress affecting mood, sleep, and menstrual regularity, ashwagandha addresses the upstream cause. The cortisol-reduction benefit (confirmed across 12 RCTs, PMID: 40746175) creates space for the HPG axis to function more normally. You can start with 300 mg daily with food. This is most relevant for women in their late 20s to 40s under sustained occupational or personal stress.

For perimenopause and menopause: Ashwagandha is a reasonable complementary approach to managing the stress, sleep, and psychological dimensions of the menopausal transition. The evidence (PMID: 34553463, 41561822) supports 300 mg twice daily for at least 8 weeks. Consider combining with magnesium glycinate for sleep, and vitamin D if levels are low — both are common deficiencies in perimenopausal women. It is not a hormone replacement and should not be positioned as one.

For sexual wellbeing: The pilot study (PMID: 26504795) suggests 300 mg twice daily for 8 weeks may improve arousal, satisfaction, and sexual distress. Consider this alongside stress management — sexual dysfunction in women is frequently stress-driven, and addressing cortisol may be the mechanism.

For PCOS: The theoretical basis is plausible but the evidence is not there yet. General stress-reduction may provide some benefit, but direct PCOS outcomes are not established. This is unlikely to help as a standalone intervention for insulin resistance or androgen excess. Consult your healthcare professional for PCOS management.

For fertility: There is no human research suggests benefits for ashwagandha improving female fertility outcomes. If you are trying to conceive, do not rely on ashwagandha for this purpose. The stress-reduction effect may indirectly support reproductive health, but this is speculative.

When NOT to use ashwagandha: Pregnant women should avoid ashwagandha — uterine-stimulating effects are documented in traditional use, and no adequate human safety studies exist in pregnancy. Women with oestrogen-sensitive conditions (certain breast cancers, endometriosis) should seek professional advice before use. If you are taking hormonal contraceptives or hormone replacement therapy, consult your prescribing physician — the interaction evidence is limited but the hormonal interplay warrants professional guidance. If you have hyperthyroidism or Graves' disease, ashwagandha's thyroid-stimulating potential may not be appropriate for you.

Should YOU Take Ashwagandha?

Dosage Guidance for Women

For women new to ashwagandha, begin with 300 mg daily with food. Assess response at 4 weeks before increasing to 600 mg if needed. Evening dosing may be preferable if sleep quality and anxiety are primary goals. With our 10:1 extract, half a teaspoon (approximately 300 mg) in warm milk, a smoothie, or golden milk is a practical starting point. See our full dosage guide for the complete framework.

Pair with magnesium for enhanced sleep benefits. Stack with reishi for deeper nervous system calming, or combine with tremella for combined stress-and-skin support — both are adaptogens with complementary mechanisms.

Frequently Asked Questions

Related reading: Ashwagandha Benefits: The Complete Guide · Ashwagandha for Anxiety and Stress · Ashwagandha for Sleep · Ashwagandha for Thyroid · Dosage Guide · Side Effects

Continue Your Research

• Ashwagandha for Hair and Skin: The Cortisol-Tissue Cascade
• Ashwagandha for Muscle Strength: The Anabolic Recovery Window Explained
• Ashwagandha for Gut Health: The Stress-Gut Axis Short-Circuit
• Ashwagandha vs Lion's Mane: The Body-Brain Divide
• Ashwagandha and Magnesium: Close the Dual Calm Gap
• Ashwagandha Research: What 1,584 Studies Tell Us

← Back to Ashwagandha Research Hub